Industry Updates
Press Releases
LANXESS receives excellent sustainability ratings
1st rank in Dow Jones Sustainability Index Europe, 4th rank worldwide
Group among the top-rated chemical companies in ISS ESG ratings
MSCI ESG confirms...
Press Releases
Intermountain Health Announces Architect Firms for Nevada’s First Comprehensive Stand-Alone Children’s Hospital
Intermountain Health today announced Shepley Bulfinch and Gensler as the two architect firms that will design the upcoming stand-alone children’s hospital in southern Nevada.
The announcement marks...
Press Releases
Introducing Next-Gen Cylindrical Laser Machining for Medical Device Manufacturing
PITTSBURGH – Aerotech Inc., a global leader in precision motion control and automation, today introduced the LaserTurn®160, the ultimate cylindrical laser machining motion platform. Designed for unparalleled precision...
Press Releases
OGT delivers superior MRD detection capabilities with new SureSeq Myeloid MRD Panel
New York, USA. Today, OGT announces the North American launch of its new next-generation sequencing (NGS) SureSeq™ Myeloid MRD Panel, which provides a flexible NGS workflow for the detection of ultra-low frequency measurable residual disease...
Press Releases
Siemens Healthineers and the American Society of Radiologic Technologists Expand Training Partnership Globally
To increase access to world-class radiography training in underserved countries worldwide
To build capacity to address the critical shortage of radiographers in low-resource settings
...
Press Releases
Interclean Shanghai 2024 transforms the Chinese cleaning and hygiene industry with innovation and opportunity
The Interclean Shanghai 2024 trade show, held from 11 – 13 December at the Shanghai New International Expo Centre, has been called an outstanding success! Industry professionals gathered in China’s business and economic...
Press Releases
Theranexus And Exeltis (INSUD PHARMA) Announce Licensing Agreement To Commercialize Theranexus TX01 For Two Rare Neurological Disorders
Exeltis will be granted an exclusive license to market and distribute Theranexus’ novel formulation TX01 for the treatment of two rare neurological diseases notably in Europe.
Theranexus will be eligible...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
